If you have friends who won't stop asking you about peptides...send them here. You can actually get paid for it.. Anyone who joins through your referral link earns you a commission. Once they're in, just go to your Skool settings and request the payout. Simple as that. Be smart about where you share your invite link though. Don't post it on other Skool groups or anywhere it'll read as spam. Stick to people who are already asking. Those are the easiest conversations anyway. To find your link on mobile: Tap the 3 dots in the top right → Invite → copy your link. Anyone who signs up through it is automatically tracked as your referral.

Has anyone tried Selank and Semax versus N-Acetyl Selank Amidate and N-Acetyl Semax Amidate? Curious as to what you thought was better..

I've seen alot of posts lately about injectable SLU-PP-332...specifically the DMSO-based solutions floating around. I want to address this directly because I think it's important for anyone in this community doing serious research. The short answer: injectable SLU-PP-332 in DMSO is a bad idea, and here's why. The Formulation Problem SLU-PP-332 is a moderately lipophilic small molecule (MW ~290 Da). DMSO can dissolve it in the vial just fine — but the moment you inject it, it hits aqueous interstitial fluid and the whole game changes. You get rapid dilution, potential supersaturation, and microcrystal formation. Those crystals can lodge in capillaries and tissue, causing sterile inflammation, granulomas, or worse if someone is foolish enough to go IV. This isn't theoretical. Lipophilic compounds without proper solubilizing excipients, think cyclodextrins, surfactants, lipid nanoparticles, PEG/Tween blends, routinely precipitate post-injection. The published preclinical work (Billon et al., 2023/2024) used carefully controlled pharmaceutical-grade vehicles for IP injection in rodents. Nobody is doing that with gray-market DMSO solutions. There's No Validated Injectable Protocol Zero published literature exists on IM, SC, or IV formulations in humans. That means: - Unknown safe injection volume and site - Unknown local tissue tolerance (pain, necrosis risk) - Unknown systemic PK when first-pass metabolism is bypassed - No human safety data - none The published rodent studies used intraperitoneal injection with pharmaceutical vehicles. That's a long way from someone pinning a DMSO solution subcutaneously. Bypassing First-Pass May Actually Be a Problem SLU-PP-332 likely undergoes CYP450 hepatic metabolism — the specific pathways aren't fully characterized yet, but that first-pass filtering is probably doing something useful. Bypass it with injection and you're potentially spiking parent drug concentrations into territory with zero dose-response data to guide you.

New Article on X about Unlocking Longevity at the Cellular Level https://x.com/startmyresearch/status/2062350509680267394

While Starting My Research does not manufacture, sell, distribute, or endorse any peptides, medications, or research compounds, we recognize that researchers often seek suppliers that prioritize transparency, testing, and quality control. The sources listed below have been selected based on factors such as: - Independent third-party testing - Certificate of Analysis (COA) availability - Product transparency - Published quality-control standards - Batch-specific documentation - Community reputation within the research space Researchers should always perform their own due diligence before purchasing any research materials. Recommended Sources: Universal BioLabs Universal BioLabs provides research materials accompanied by batch-specific Certificates of Analysis and independent third-party testing documentation. Highlights include: - Independent third-party testing - HPLC and Mass Spectrometry verification - Sterility testing where applicable - Batch-specific COAs available prior to purchase - Transparent quality-control procedures Visit: UniversalBioLabs.com Use code JFDISCOUNT for 15% off BioLongevity Labs BioLongevity Labs focuses on research-grade compounds supported by quality-control documentation and third-party verification. Highlights include: - Third-party laboratory testing - Batch-specific quality documentation - Certificate of Analysis availability - Research-focused product catalog - Transparent testing standards Visit: BioLongevityLabs.store Use code JFDISCOUNT for 15% off Important Disclaimer: Starting My Research is an independent educational publisher and does not sell peptides, medications, supplements, or research compounds. The inclusion of a supplier on this page does not constitute an endorsement, recommendation, or guarantee of any product, service, claim, or outcome. Researchers are solely responsible for conducting their own due diligence, reviewing available testing documentation, and complying with all applicable laws and regulations.